Our read is that taking curcumin is partially supported, with some experts noting potential benefits for inflammation and cognitive function, while others raise concerns about bioavailability, side effects, and impact on androgen levels.
Curcumin, a compound found in turmeric, has been linked to various potential benefits, including activating anti-inflammatory genes and detoxifying enzymes, improving working memory, and alleviating joint pain.
However, experts also highlight significant drawbacks, such as its variable and extremely low systemic bioavailability, potential negative effects on testosterone and DHT levels, and the presence of oxalates in high doses.
Some experts recommend specific formulations like TheraCurmin or phytosomal curcumin for certain conditions, while others caution against high-dose supplementation due to potential adverse effects and a lack of robust clinical trial success.
Rhonda Patrick suggests taking curcumin several hours after a workout. For joint pain, Rhonda Patrick noted that phytosomal curcumin (Meriva) at a dose of 2 grams has been shown to alleviate symptoms. Peter Attia recommends TheraCurmin over standard curcumin for high-risk patients. Rhonda Patrick also mentioned her mother takes 1 gram of phytosomal curcumin every 2 hours on bad migraine days.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Paul Saladino advised twice against consuming high amounts of curcumin from supplements, powders, or golden milk due to the high oxalate load. He also stated that curcumin supplementation had no effect on serum total LDL cholesterol, triglycerides, and HDL-C levels in a 2013 study, and that curcumin has variable and extremely low systemic bioavailability when dosed orally, even at maximum tolerated doses. Paul Saladino cautioned twice that turmeric should not be used to address inflammation, as it may have negative side effects like lowering androgens. He also noted that curcumin showed no significant effect on psoriasis index in a prospective clinical trial that was not randomized, and that no double-blind, placebo-controlled clinical trial of curcumin has been successful, according to a 2017 paper. Andrew Huberman generally does not recommend high-dose curcumin supplements, though cooking with curcumin is acceptable. Paul Saladino pointed out that curcumin has activity against the hERG channel, which is associated with potential cardiac toxicity. Andrew Huberman stated three times that turmeric supplementation can significantly reduce DHT levels and negatively impact feelings of vitality, and twice that individuals with low DHT levels or androgen receptor insensitivity should avoid bioavailable curcuminoids and black pepper extract. Andrew Huberman also noted five times that curcumin is a potent inhibitor of dihydrotestosterone (DHT), which can lead to reductions in libido in sensitive individuals. Paul Saladino reported that curcumin doses ranging from 0.9 to 3.6 grams per day for one to four months can cause adverse effects including nausea, diarrhea, and an increase in serum alkaline phosphatase and lactate dehydrogenase. He also mentioned that a 2018 double-blind randomized placebo-controlled pilot study showed changes in the gut microbiota when turmeric was administered, but the clinical significance or benefit of these changes is unknown. Paul Saladino emphasized three times that turmeric's anti-inflammatory properties do not fix the underlying problem causing inflammation. Paul Saladino also noted twice that turmeric was found to cause dose and time-dependent induction of chromosomal aberrations in mammalian cell lines at concentrations of 10 micrograms/ml in 1976. He also stated that curcumin shows cytotoxicity against normal human lymphocytes in addition to cancer cells, and that curcumin concentrations of 2.5 and 5 micrograms/ml have been shown to induce DNA damage to both mitochondrial and nuclear genomes in cells. Paul Saladino described the chemical structure of curcumin, containing two alpha-beta unsaturated ketones, mediates a Michael addition reaction that can generate reactive oxygen species, irreversibly modify antioxidant enzyme thioredoxin reductase, induce topoisomerase II-mediated DNA damage, and inactivate the tumor suppressor gene p53. He also mentioned that large doses (8-12 grams/day) of curcumin can cause adverse events like diarrhea, rash, and headache in up to 30% of participants, while lower doses are likely benign. Andrew Huberman noted twice that curcumin can inhibit cytochrome P450, requiring caution for individuals taking anticoagulant medications, and twice that some individuals are sensitive to curcumin, experiencing a reduction in DHT which can negatively impact libido, drive, aggression, and mood. Andrew Huberman also stated that curcumin has potent anti-inflammatory properties that can potentially blunt adaptation responses to exercise. Paul Saladino questioned the benefit of plant compounds like curcumin for healthy individuals eating meat and organs, despite their potential anti-inflammatory effects.
The verdict could change with more successful double-blind, placebo-controlled clinical trials demonstrating curcumin's efficacy and safety, particularly for systemic effects. Further research clarifying the clinical significance of gut microbiota changes and the long-term impact on androgen levels would also be influential. Additionally, studies addressing the underlying causes of inflammation rather than just symptomatic relief would be valuable.
Mechanistic and trial evidence converge on a real, replicable effect.
Mechanistic and trial evidence converge on a real, replicable effect.
Piperine in black pepper inhibits liver enzymes that clear polyphenols, increasing their half-life and bioavailability.
The effect size is large enough to matter clinically, not just statistically.
Mechanistic and trial evidence converge on a real, replicable effect.
Animal-model results don't translate to the human protocol being recommended.
Confounding and publication bias inflate the apparent benefit.
The headline effect shrinks once you account for trial quality.
Confounding and publication bias inflate the apparent benefit.
The headline effect shrinks once you account for trial quality.